Skip to main content

Table 3 Integration of the MDT flagging process into routine care (ranked by percent of patients discussed among those flagged)

From: A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial

 

Flagged

 

Discussed1 among those flagged

Characteristic

N1^

n1 (% of N1)

Adjusted # RR (95% CI)

N2^^

n2 (% of N2)

Adjusted # RR (95% CI)

All patients:

407

318 (78%)

 

318

220 (69%)

 

Hospital

 Site 6

36

34 (94%)

1.13 (1.03, 1.25)

34

34 (100%)

3.30 (2.70, 4.03)

 Site 5

19

6 (32%)

0.46 (0.16, 1.32)

6

6 (100%)

3.14 (2.50, 3.95)

 Site 1

48

32 (67%)

0.94 (0.81, 1.09)

32

30 (94%)

2.94 (2.29, 3.78)

 Site 4

54

40 (74%)

0.96 (0.78, 1.17)

40

36 (90%)

2.92 (2.29, 3.72)

 Site 8

52

48 (92%)

1.13 (1.07, 1.21)

48

40 (83%)

2.74 (2.23, 3.37)

 Site 2

12

8 (67%)

0.79 (0.75, 0.84)

8

6 (75%)

2.47 (2.03, 3.02)

 Site 7

34

25 (74%)

0.94 (0.67, 1.33)

25

18 (72%)

2.37 (1.59, 3.54)

 Site 9

32

29 (91%)

1.42 (1.24, 1.63)

29

20 (69%)

2.09 (1.29, 3.37)

 Site 3

120

96 (80%)

ref.

96

30 (31%)

ref.

 p value

  

< 0.001

  

< 0.001

Insurance

 Private

329

280 (85%)

ref.

280

190 (68%)

ref.

 Public

78

38 (49%)

0.56 (0.42, 0.75)

38

30 (79%)

1.15 (0.89, 1.49)

 p value

  

< 0.001

  

0.282

  1. ^Intervention group patients
  2. ^^Intervention group patients who were flagged
  3. 1Patient discussed at MDT meeting within 4 months after prostatectomy
  4. #Adjusted for site and insurance with urologist as the GEE clustering variable